Emory University’s BeOne Medicines Ltd ONC Stock Holding History

Emory University’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-17,807	Closed	-$2.21M	–	41
2019 Q2	$2.21M	Sell	17,807 -232	-1%	-$29.4K	1.55%	25
2019 Q1	$2.38M	Sell	18,039 -129	-0.7%	-$17.4K	1.67%	21
2018 Q4	$2.55M	Buy	18,168 +1,526	+9%	+$202K	2.01%	8
2018 Q3	$2.87M	Buy	16,642 +2,321	+16%	+$390K	1.88%	12
2018 Q2	$2.2M	Sell	14,321 -4,849	-25%	-$865K	1.46%	30
2018 Q1	$3.22M	Sell	19,170 -2,786	-13%	-$377K	2.3%	4
2017 Q4	$2.15M	Sell	21,956 -1,105	-5%	-$101K	1.84%	7
2017 Q3	$2.39M	Sell	23,061 -18,248	-44%	-$1.36M	1.89%	6
2017 Q2	$1.86M	Sell	41,309 -16,345	-28%	-$644K	1.64%	7
2017 Q1	$2.11M	Buy	+57,654	New	+$2.1M	1.99%	12

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Emory University's ONC Position: Q3 2019 in Review

Emory University sold out of BeOne Medicines Ltd (ONC) in Q3 2019, closing a stake of 17,807 shares — an estimated $2.21M sold.

Emory University first reported a position in ONC in Q1 2017 and held it in 10 quarters. The position peaked at $3.22M in Q1 2018. 196 funds tracked by Wall St. Rank hold ONC as of Q3 2019.

Emory University reported no remaining BeOne Medicines Ltd position as of Q3 2019 after selling out during the quarter.
Emory University sold 17,807 BeOne Medicines Ltd shares in Q3 2019, an estimated $2.21M.
Emory University first reported a position in BeOne Medicines Ltd in Q1 2017 and held it in 10 quarters.
Emory University's BeOne Medicines Ltd position peaked at $3.22M in Q1 2018.
196 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2019.

Based on Emory University's 13F filing for Q3 2019, filed 14 Nov 2019.